Retatrutide is a triple hormone receptor agonist that acts on the GIP, GLP-1, and glucagon pathways and is currently in development for the treatment of obesity. In recent times, the retatrutide peptide has gained attention across fitness and bodybuilding communities, especially for weight loss, even though it is still considered an investigational drug. Eli Lilly developed it, and it is not...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek